"RNA-Binding Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA.
Descriptor ID |
D016601
|
MeSH Number(s) |
D12.776.157.725 D12.776.664.962
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "RNA-Binding Proteins".
Below are MeSH descriptors whose meaning is more specific than "RNA-Binding Proteins".
This graph shows the total number of publications written about "RNA-Binding Proteins" by people in this website by year, and whether "RNA-Binding Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 7 | 0 | 7 |
1995 | 9 | 2 | 11 |
1996 | 8 | 3 | 11 |
1997 | 2 | 2 | 4 |
1998 | 8 | 7 | 15 |
1999 | 14 | 2 | 16 |
2000 | 5 | 5 | 10 |
2001 | 9 | 3 | 12 |
2002 | 11 | 5 | 16 |
2003 | 3 | 2 | 5 |
2004 | 10 | 8 | 18 |
2005 | 11 | 11 | 22 |
2006 | 8 | 6 | 14 |
2007 | 7 | 7 | 14 |
2008 | 9 | 10 | 19 |
2009 | 10 | 18 | 28 |
2010 | 13 | 12 | 25 |
2011 | 17 | 10 | 27 |
2012 | 12 | 16 | 28 |
2013 | 13 | 17 | 30 |
2014 | 18 | 13 | 31 |
2015 | 17 | 10 | 27 |
2016 | 25 | 6 | 31 |
2017 | 20 | 10 | 30 |
2018 | 12 | 14 | 26 |
2019 | 18 | 9 | 27 |
2020 | 19 | 11 | 30 |
2021 | 23 | 8 | 31 |
2022 | 9 | 17 | 26 |
2023 | 3 | 9 | 12 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "RNA-Binding Proteins" by people in Profiles.
-
MATR3 pathogenic variants differentially impair its cryptic splicing repression function. FEBS Lett. 2024 Feb; 598(4):415-436.
-
RBFOX2 deregulation promotes pancreatic cancer progression and metastasis through alternative splicing. Nat Commun. 2023 Dec 19; 14(1):8444.
-
circ-hnRNPU inhibits NONO-mediated c-Myc transactivation and mRNA stabilization essential for glycosylation and cancer progression. J Exp Clin Cancer Res. 2023 Nov 23; 42(1):313.
-
Ubiquitin-proteasome system regulation of a key gene regulatory factor, Paf1C. Gene. 2024 Feb 05; 894:148004.
-
Phase I Results of Bromodomain and Extra-Terminal Inhibitor PLX51107 in Combination with Azacitidine in Patients with Relapsed/Refractory Myeloid Malignancies. Clin Cancer Res. 2023 11 01; 29(21):4352-4360.
-
Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA-binding proteins. Cell Rep Med. 2023 11 21; 4(11):101255.
-
Clinical exome sequencing efficacy and phenotypic expansions involving anomalous pulmonary venous return. Eur J Hum Genet. 2023 12; 31(12):1430-1439.
-
Effectors and effects of arginine methylation. Biochem Soc Trans. 2023 04 26; 51(2):725-734.
-
Therapeutic targeting of CNBP phase separation inhibits ribosome biogenesis and neuroblastoma progression via modulating SWI/SNF complex activity. Clin Transl Med. 2023 04; 13(4):e1235.
-
Disruption of SLFN11 Deficiency-Induced CCL2 Signaling and Macrophage M2 Polarization Potentiates Anti-PD-1 Therapy Efficacy in Hepatocellular Carcinoma. Gastroenterology. 2023 06; 164(7):1261-1278.